Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Johnson

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
British Journal of Haematology|December 21, 2000
Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescueA S Protheroe, C Pickard, P W Johnson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2022
Corrigendum to "Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 31 (2020) 17-29]E Zucca, L Arcaini, C Buske, et al.
Leukemia & Lymphoma|April 7, 2000
FLUDAP: salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphomaJ A Child, S A Johnson, S Rule, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upE Zucca, L Arcaini, C Buske, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with responseJ M Foran, D Cunningham, B Coiffier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2015
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upH Tilly, M Gomes da Silva, U Vitolo, et al.
Seminars in Oncology|October 1, 1993
Fludarabine in low-grade lymphomaA Pigaditou, A Z Rohatiner, J S Whelan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
A randomized trial of two etoposide schedules in small-cell lung cancer: the influence of pharmacokinetics on efficacy and toxicityP I Clark, M L Slevin, S P Joel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphomaA Z Rohatiner, P W Johnson, C G Price, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single centerP W Johnson, A Z Rohatiner, J S Whelan, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
British Journal of Haematology|December 21, 2000
Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescueA S Protheroe, C Pickard, P W Johnson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2022
Corrigendum to "Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 31 (2020) 17-29]E Zucca, L Arcaini, C Buske, et al.
Leukemia & Lymphoma|April 7, 2000
FLUDAP: salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphomaJ A Child, S A Johnson, S Rule, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upE Zucca, L Arcaini, C Buske, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with responseJ M Foran, D Cunningham, B Coiffier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2015
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upH Tilly, M Gomes da Silva, U Vitolo, et al.
Seminars in Oncology|October 1, 1993
Fludarabine in low-grade lymphomaA Pigaditou, A Z Rohatiner, J S Whelan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
A randomized trial of two etoposide schedules in small-cell lung cancer: the influence of pharmacokinetics on efficacy and toxicityP I Clark, M L Slevin, S P Joel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphomaA Z Rohatiner, P W Johnson, C G Price, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single centerP W Johnson, A Z Rohatiner, J S Whelan, et al.
Pageof 14